Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.142EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.523EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.36.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.418EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.389EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.53EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.363EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.405EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.282EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.228EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.174EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.88 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.106 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.346EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.93EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.512EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.349EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.265EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.401EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.362EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FW.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BS.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CA.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.453EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.637.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.79EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BG.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KN.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XASEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.53EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.53 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.599EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.128EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used